Founded in 2013, Lumiata (formerly MEDgle) applies big data-driven medical science to patient data in order to optimize every health care interaction. The company delivers real-time predictive analytics that help hospital networks and insurance carriers provide higher quality care to more patients in less time. To produce accurate insights and predictions related to symptoms, diagnoses, procedures and medications, Lumiata developed the world's first medical graph, which organizes and analyzes hundreds of millions of valuable data points. Lumiata is a venture-backed company based in Silicon Valley and composed of clinicians, data scientists, and experts in care delivery.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/08/14 | $4,000,000 | Series A | ||
| 09/11/14 | $6,000,000 | Series A-1 |
BlueCross BlueShield Venture Partners | undisclosed |
| 05/27/16 | $10,000,000 |
Blue Equity BlueCross BlueShield Venture Partners Intel Capital | undisclosed | |
| 07/10/18 | $11,000,000 | Venture |
BlueCross BlueShield Venture Partners Intel Capital | undisclosed |
| 01/14/21 | $14,000,000 | Series B |
AllegisNL Capital Blue Venture Fund Defy.vc | undisclosed |
